Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Gross Profit: 2022-2024

Historic Gross Profit for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to $36.6 million.

  • Stoke Therapeutics' Gross Profit rose 117.25% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.6 million, marking a year-over-year increase of 1128.17%. This contributed to the annual value of $36.6 million for FY2024, which is 316.34% up from last year.
  • As of FY2024, Stoke Therapeutics' Gross Profit stood at $36.6 million, which was up 316.34% from $8.8 million recorded in FY2023.
  • In the past 5 years, Stoke Therapeutics' Gross Profit ranged from a high of $36.6 million in FY2024 and a low of $8.8 million during FY2023.
  • Its 3-year average for Gross Profit is $19.2 million, with a median of $12.4 million in 2022.
  • In the last 5 years, Stoke Therapeutics' Gross Profit decreased by 29.22% in 2023 and then spiked by 316.34% in 2024.
  • Yearly analysis of 3 years shows Stoke Therapeutics' Gross Profit stood at $12.4 million in 2022, then declined by 29.22% to $8.8 million in 2023, then soared by 316.34% to $36.6 million in 2024.